94 related articles for article (PubMed ID: 12107206)
1. Cognitive effects of short-term manipulation of serum sex steroids in healthy young men.
Cherrier MM; Anawalt BD; Herbst KL; Amory JK; Craft S; Matsumoto AM; Bremner WJ
J Clin Endocrinol Metab; 2002 Jul; 87(7):3090-6. PubMed ID: 12107206
[TBL] [Abstract][Full Text] [Related]
2. The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone.
Herbst KL; Anawalt BD; Amory JK; Matsumoto AM; Bremner WJ
J Clin Endocrinol Metab; 2003 Mar; 88(3):1167-73. PubMed ID: 12629101
[TBL] [Abstract][Full Text] [Related]
3. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
[TBL] [Abstract][Full Text] [Related]
4. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
[TBL] [Abstract][Full Text] [Related]
5. Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial.
Anawalt BD; Amory JK; Herbst KL; Coviello AD; Page ST; Bremner WJ; Matsumoto AM
J Androl; 2005; 26(3):405-13. PubMed ID: 15867009
[TBL] [Abstract][Full Text] [Related]
6. A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations.
Anawalt BD; Bebb RA; Bremner WJ; Matsumoto AM
J Androl; 1999; 20(3):407-14. PubMed ID: 10386821
[TBL] [Abstract][Full Text] [Related]
7. Novel male hormonal contraceptive combinations: the hormonal and spermatogenic effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist.
Matthiesson KL; Amory JK; Berger R; Ugoni A; McLachlan RI; Bremner WJ
J Clin Endocrinol Metab; 2005 Jan; 90(1):91-7. PubMed ID: 15509637
[TBL] [Abstract][Full Text] [Related]
8. Effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist on spermatogenesis and intratesticular steroid levels in normal men.
Matthiesson KL; Stanton PG; O'Donnell L; Meachem SJ; Amory JK; Berger R; Bremner WJ; McLachlan RI
J Clin Endocrinol Metab; 2005 Oct; 90(10):5647-55. PubMed ID: 16030154
[TBL] [Abstract][Full Text] [Related]
9. Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception.
Kamischke A; Plöger D; Venherm S; von Eckardstein S; von Eckardstein A; Nieschlag E
Clin Endocrinol (Oxf); 2000 Jul; 53(1):43-52. PubMed ID: 10931079
[TBL] [Abstract][Full Text] [Related]
10. Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression.
Anawalt BD; Herbst KL; Matsumoto AM; Mulders TM; Coelingh-Bennink HJ; Bremner WJ
Fertil Steril; 2000 Oct; 74(4):707-14. PubMed ID: 11020511
[TBL] [Abstract][Full Text] [Related]
11. Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen.
Coviello AD; Bremner WJ; Matsumoto AM; Herbst KL; Amory JK; Anawalt BD; Yan X; Brown TR; Wright WW; Zirkin BR; Jarow JP
J Androl; 2004; 25(6):931-8. PubMed ID: 15477366
[TBL] [Abstract][Full Text] [Related]
12. The role of aromatization in testosterone supplementation: effects on cognition in older men.
Cherrier MM; Matsumoto AM; Amory JK; Ahmed S; Bremner W; Peskind ER; Raskind MA; Johnson M; Craft S
Neurology; 2005 Jan; 64(2):290-6. PubMed ID: 15668427
[TBL] [Abstract][Full Text] [Related]
13. Hormonal contraception in Chinese men: variations in suppression of spermatogenesis with injectable testosterone undecanoate and levonorgestrel implants.
Liu ST; Gui YL; Lin CH; He CH
Asian J Androl; 2004 Mar; 6(1):41-6. PubMed ID: 15064833
[TBL] [Abstract][Full Text] [Related]
14. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
15. Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men.
McLachlan RI; O'Donnell L; Stanton PG; Balourdos G; Frydenberg M; de Kretser DM; Robertson DM
J Clin Endocrinol Metab; 2002 Feb; 87(2):546-56. PubMed ID: 11836283
[TBL] [Abstract][Full Text] [Related]
16. An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations.
Kamischke A; Heuermann T; Krüger K; von Eckardstein S; Schellschmidt I; Rübig A; Nieschlag E
J Clin Endocrinol Metab; 2002 Feb; 87(2):530-9. PubMed ID: 11836281
[TBL] [Abstract][Full Text] [Related]
17. A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel.
Endrikat J; Blode H; Gerlinger C; Rosenbaum P; Kuhnz W
Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):79-90. PubMed ID: 12201326
[TBL] [Abstract][Full Text] [Related]
18. Levonorgestrel implants enhanced the suppression of spermatogenesis by testosterone implants: comparison between Chinese and non-Chinese men.
Wang C; Wang XH; Nelson AL; Lee KK; Cui YG; Tong JS; Berman N; Lumbreras L; Leung A; Hull L; Desai S; Swerdloff RS
J Clin Endocrinol Metab; 2006 Feb; 91(2):460-70. PubMed ID: 16278260
[TBL] [Abstract][Full Text] [Related]
19. Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment.
McLachlan RI; Robertson DM; Pruysers E; Ugoni A; Matsumoto AM; Anawalt BD; Bremner WJ; Meriggiola C
J Clin Endocrinol Metab; 2004 Jan; 89(1):142-9. PubMed ID: 14715841
[TBL] [Abstract][Full Text] [Related]
20. Contraceptive steroids influence the hemostatic activation state in healthy men.
Zitzmann M; Junker R; Kamischke A; Nieschlag E
J Androl; 2002; 23(4):503-11. PubMed ID: 12065457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
